欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5343/003
药品名称Ranolazine DEMO
活性成分
    • ranolazine 750.0 mg
剂型Prolonged-release tablet
上市许可持有人DEMO S.A. Pharmaceutical Industry 21st Km National Road Athens-Lamia, Krioneri, Attiki, 145 68 Greece
参考成员国 - 产品名称Netherlands (NL)
Lazela 750 mg tabletten met verlengde afgifte
互认成员国 - 产品名称
    • Greece (GR)
许可日期2022/05/12
最近更新日期2024/04/15
药物ATC编码
    • C01EB18 ranolazine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase